An LGR4 agonist activates the GSK-3β pathway to inhibit RANK-RANKL signaling during osteoclastogenesis in bone marrow-derived macrophages

导出原文传递

翻译打印收藏纠错

作者： Jang, Yuria ^[1] ; Lee, Hyeonjoon ; Cho, Yongjin ; Choi, Eunseo ; Jo, Suenghwan ; Sohn, Hong Moon ; Kim, Beom Chang ; Ko, Young Jong ; Lim, Wonbong

作者单位： Chosun University,Chosun Univ ^[1]

关键词 leucine-rich repeat-containing G-protein-coupled receptor 4 receptor activator of nuclear factor-kappa B ligand osteoclast osteoporosis receptor activator of nuclear factor-kappa B glycogen synthase kinase-3 beta DENOSUMAB RECEPTOR DIFFERENTIATION PREVENTION MANAGEMENT

发布时间 2024-05-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

International journal of molecular medicine

2024年53卷1期

Article Number 10-Article Number 10页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

An LGR4 agonist activates the GSK-3β pathway to inhibit RANK-RANKL signaling during osteoclastogenesis in bone marrow-derived macrophages

International journal of molecular medicine

相似文献

International journal of molecular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

An LGR4 agonist activates the GSK-3β pathway to inhibit RANK-RANKL signaling during osteoclastogenesis in bone marrow-derived macrophages

International journal of molecular medicine

相似文献

International journal of molecular medicine

相关期刊

检索历史清除